Angiopeptin; Autogel; BIM-23014; BIM 23014; BIM23014; DC-13-116; Ipstyl; Somatuline; Lanreotidum; Lanreotida; Lanreotide; LS-153748; LS 153748; LS153748
H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bond)
Long-term Storage Conditions
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.
Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, with higher affinity to peripheral receptors, and has similar activity.
Areas of Interest
Acromegaly & Neuroendocrine tumors